| Product Information |
|
| Registration Number |
VR-4131
|
| Generic Name |
Modified Live Recombinant Canine Distemper Virus
(CDV) + Canine Adenovirus Type 2 (CAV-2) + Canine Parvovirus (CPV) + Canine Parainfluenza Virus (CPIV) + Canine Coronavirus Vaccine (CCV) (Vet.)
|
| Brand Name |
Recombitek C4/CV
|
| Dosage Strength |
Each dose 1.0 mL of vaccine contains the following through expiration:
Active Ingredients:
Canarypox/ Canine distemper virus recombinant, CP258, Rentschler/Onderstepoort
strain, at least ................................................................................... >106.4TCID50
Canine adenovirus type 2, Toronto A/26/61 strain, at least ...................... >104.3 TCID50
Canine parvovirus, 780916 strain, at least ............................................. >103.3 FAID50
Canine parainfluenza virus, D-008 strain, at least ................................... >103.9 TCID50
Canine coronavirus, K-378/51 strain, at least........................................... >103.6 TCID50 "TCID-Tissue Culture Infective Dose "FAID- Fluorescent Antibody Infective Dess
|
| Dosage Form |
Lyophilized Powder for
Injection (IM/SC)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Each set contains:
Type I Glass Vial with rubber stopper and aluminum seal containing the lyophilized powder + Type I Glass vial containing the diluent (sterile water) (Box of 25's)
|
| Pharmacologic Category |
Veterinary Vaccine
|
| Manufacturer |
Boehringer Ingelheim Animal Health USA Inc.
|
| Country of Origin |
U.S.A.
|
| Trader |
N/A
|
| Importer |
Boehringer Ingelheim Animal Health Philippines, Inc.
|
| Distributor |
Boehringer Ingelheim Animal Health Philippines, Inc.
|
| Application Type |
Renewal
|
| Issuance Date |
16 February 2022
|
| Expiry Date |
16 February 2027
|